REG - Iconic Labs PLC - Directorate Change

Iconic LabsAnnouncement

14/12/2022 18:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221214:nRSN7594Ja&default-theme=true

RNS Number : 7594J  Iconic Labs PLC  14 December 2022

14 December 2022

 

Marija Hrebac Appointed to the Iconic Board of Directors

 

Iconic Labs PLC ("Iconic") is pleased to announce that Marija Hrebac has been formally appointed to the Board of Directors.
Marija Hrebac's appointment to the Board of Directors was originally announced to the market on 24 May 2021 but was subject to regulatory checks.
Those regulatory checks were completed satisfactorily on 4 June 2021 but in view of the appointment of the Joint Administrators to Iconic on 4 June 2021, it was not possible to formalize Marija Hrebac's appointment with the corresponding filings at Companies House.
Since the original announcement and satisfactory completion of regulatory checks, Marija Hrebac has confirmed that there have been no changes to her circumstances that would impact her qualification as a director, including, bankruptcy filings, insolvency filings, litigation, blacklists, sanctions or any other factor which could damage Iconic's reputation.
Given that the CVA has been passed by Iconic's creditors of the and approved by shareholders, and that the Administration has ended and control returned to the Directors, Marija Hrebac's appointment to the Board of Directors has been formalized with immediate effect and the corresponding filings have been made with Companies House.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFFDFALEESEEE